In contrast, 34/50 genes negatively related to PRR11 had the possibility of being potential protective markers in BLCA patients, and 5 of them were statistically significant (IDUA, BATF, TNFRSF14, RILP, TMEM219). This evidence concerns the gene RILP and bladder transitional cell carcinoma.